Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Vertex Pharmaceuticals Inc
Discovers and develops novel, small molecule pharmaceuticals

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases.

It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune diseases, such as rheumatoid arthritis; cancer, inflammatory bowel disease; and neurological disorders, including pain, Huntington's disease and multiple sclerosis.

The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
Sales per Businesses
20142015Delta
USD (in Million)%USD (in Million)%
Pharmaceuticals580.42100%1,032100% +77.86%
Sales per Regions
20142015Delta
USD (in Million)%USD (in Million)%
United States361.0762.2%763.3273.9% +111.4%
Europe197.6134%219.6021.3% +11.13%
Other21.733.7%49.424.8% +127.45%
Managers
NameAgeSinceTitle
Jeff Leiden612009Chairman, President & Chief Executive Officer
Ian F. Smith512001EVP, Chief Operating & Financial Officer
Jeffrey A. Chodakewitz, MD612014Chief Medical Officer & Executive Vice President
David Matthew Altshuler MD, PhD522012Chief Scientific Officer & EVP-Global Research
Joshua S. Boger, PhD661989Director
Bruce I. Sachs, MBA571998Lead Independent Director
Elaine S. Ullian691997Lead Independent Director
Margaret G. McGlynn, MBA572011Independent Director
Terrence C. Kearney, MBA622011Independent Director
Yuchun Lee, MBA512012Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 248,301,000 246,179,929 99.1% 0 0.0% 99.1%
Shareholders
NameEquities%
T. Rowe Price Associates, Inc. 21,860,325 8.80%
Capital Research & Management Co. (World Investors) 20,758,133 8.36%
Fidelity Management & Research Co. 19,506,583 7.86%
The Vanguard Group, Inc. 15,914,094 6.41%
Wellington Management Co. LLP 14,920,158 6.01%
BlackRock Fund Advisors 13,350,517 5.38%
SSgA Funds Management, Inc. 11,774,161 4.74%
ClearBridge Investments LLC 8,649,358 3.48%
Columbia Management Investment Advisers LLC 7,775,790 3.13%
JPMorgan Investment Management, Inc. 7,339,008 2.96%
Holdings
NameEquities%Valuation
Crispr Therapeutics AG (CRSP) 2,472,3016.21%43,883,343 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
VERTEX PHARMACEUTICALS..17.48%21 279
AMGEN, INC.18.42%127 119
CELGENE CORPORATION3.19%92 788
GILEAD SCIENCES, INC.-3.24%90 681
REGENERON PHARMACEUTIC..1.23%39 273
ACTELION LTD22.45%28 907
GENMAB A/S18.93%12 127
TESARO INC41.49%10 144
EXELIXIS, INC.55.00%6 480
HUALAN BIOLOGICAL ENGI..--.--%4 770
TONGHUA DONGBAO PHARMA..-5.43%4 249
NEUROCRINE BIOSCIENCES..13.44%3 711
BIOCON LTD19.28%3 326
ULTRAGENYX PHARMACEUTI..9.40%3 262
INTERCEPT PHARMACEUTIC..15.46%3 046
BLUEBIRD BIO INC23.58%3 003
CHINA BIOLOGIC PRODUCT..1.29%2 909
BEIJING SL PHARMACEUTI..--.--%2 805
CLOVIS ONCOLOGY INC41.81%2 713
KITE PHARMA INC22.68%2 677
PEPTIDREAM INC-14.47%2 629
Sector Bio Therapeutic Drugs
Vertex Pharmaceuticals Inc : Connections
DataGravity, Inc.
Museum of Science
The American Institute of Certified Public Accountants
The Brigham & Women's Hospital, Inc.
Institute of Chartered Accountants in England & Wales
Nantero, Inc.
The Financial Executives Institute
iControl Networks, Inc.
Institute of Medicine
Clarus Ventures LLC
Infectious Diseases Society of America
Massachusetts Workforce Board Association
The American Society for Clinical Pharmacology & Therapeutics
SpiderCloud Wireless, Inc.
Vertex Pharmaceuticals
Jibo, Inc.
New England Aquarium Corp.
The Boston Private Industry Council, Inc.
Massachusetts Institute of Technology
Abington Friends School
The Broad Institute, Inc.
The Alliance for Business Leadership
Whitehead Institute for Biomedical Research
WGBH Educational Foundation
American Society for Clinical Investigation
Massachusetts Life Sciences Center
Association of American Physicians
Accelerated Cure Project for Multiple Sclerosis
Alkeus Pharmaceuticals, Inc.
SimpliVity Corp.
American Academy of Arts & Sciences
GreatCall, Inc.
Clarabridge, Inc.
OneCloud Software, Inc.
Massachusetts Mutual Life Insurance Co.
Charles River Ventures, Inc.
Celebrity Series of Boston, Inc.
Macp Organization
The Hastings Center
Biotechnology Innovation Organization
Massachusetts Life Sciences Collaborative
Orphan Technologies Ltd.
New England Healthcare Institute
Harvard Medical School
Allego, Inc.
Wesleyan University
General Catalyst Partners LLC
Company contact information
50 avenue Northern
US-MA 02110 Boston, Massachusetts
États-Unis (les)

Phone : +1 617 444 6100
Fax : +1 617 444 6680
Internet : http://www.vpharm.com
Markets and indexes
- NASDAQ All Markets
- Nasdaq Global Select Market
- Nasdaq 100 / SP500
Stock Exchange Codes
- ISIN Code :  US92532F1003
- Bloomberg Code :  VRTX:US
- Reuters Code :  VRTX.O
- Datastream Code :  
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem